| |
| |
|
| Insider
Information: |
Goldberg Mark Alan |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
79,501 |
|
|
Indirect Shares
|
11,497 |
|
|
| Direct
Value |
$1,729,577 |
|
|
|
Indirect Value
|
$3,065 |
|
|
| Total
Shares |
90,998 |
|
|
| Total
Value |
$1,732,642 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -26.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
|
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
|
2014-09-19 |
562 |
2013-01-02 |
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
24,828 |
2024-03-29 |
11,497 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
Director |
2021-01-04 |
38,099 |
2018-12-19 |
0 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
16,012 |
2020-06-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-03-03 |
4 |
B |
$59.98 |
$299,900 |
D/D |
5,000 |
10,812 |
0.01 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
13,412 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
16,012 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-06-30 |
4 |
A |
$18.87 |
$16,870 |
D/D |
894 |
59,088 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-09-29 |
4 |
A |
$15.87 |
$16,870 |
D/D |
1,063 |
60,151 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-10-30 |
4 |
OE |
$15.08 |
$150,800 |
D/D |
10,000 |
60,151 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-10-30 |
4 |
OE |
$14.70 |
$147,000 |
D/D |
10,000 |
70,151 |
0 |
- |
|
| IMGN |
Immunogen Inc |
|
– • – |
2023-12-29 |
4 |
A |
$29.65 |
$16,871 |
D/D |
569 |
60,720 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
|
– • – |
2024-03-29 |
4 |
A |
$3.00 |
$13,752 |
D/D |
4,584 |
24,828 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2011-11-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
800 |
|
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2012-11-08 |
4 |
B |
$11.27 |
$33,804 |
D/D |
3,000 |
3,800 |
2.39 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2014-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,100 |
|
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2016-03-04 |
4 |
B |
$4.77 |
$49,630 |
D/D |
10,397 |
11,497 |
2.39 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2016-12-15 |
4 |
B |
$1.80 |
$36,000 |
D/D |
20,000 |
23,800 |
2.39 |
- |
|
| IMGN |
Immunogen Inc |
Director |
– • – |
2018-11-06 |
4 |
B |
$5.76 |
$172,800 |
D/D |
30,000 |
53,800 |
2.39 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2018-12-19 |
4 |
B |
$3.19 |
$31,897 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-04-01 |
4 |
A |
$1.28 |
$13,734 |
D/D |
10,730 |
20,730 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
1,312 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
3,562 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-07-01 |
4 |
A |
$1.79 |
$13,874 |
D/D |
7,751 |
28,481 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2020-10-01 |
4 |
A |
$2.25 |
$13,874 |
D/D |
6,166 |
34,647 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-10-07 |
4 |
AS |
$100.00 |
$545,400 |
D/D |
(5,454) |
3,562 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-10-07 |
4 |
OE |
$19.53 |
$106,517 |
D/D |
5,454 |
9,016 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-10-19 |
4 |
AS |
$105.00 |
$572,775 |
D/D |
(5,455) |
3,562 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-10-19 |
4 |
OE |
$19.53 |
$106,536 |
D/D |
5,455 |
9,017 |
0 |
- |
|
64 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
